Showing 191-200 of 3897 results for "".
What Every Dermatologist Must Know About the History of Black Hair
https://practicaldermatology.com/topics/hair-nails/what-every-dermatologist-must-know-about-the-history-of-black-hair/23996/Knowledge of the historical, cultural, and social significance of hairstyles of Black patients may reduce implicit bias amongst dermatologists. In this article, Brooke Jackson, MD, FAAD, and Aliya Rodriguez, BS, explore the unique history and cultral impact of black hair.The Microbiome: What Do We Know Now?
https://practicaldermatology.com/topics/atopic-dermatitis/the-microbiome-what-do-we-know-now/23122/Questions and answers about the microbiome and its role in influencing cutaneous health.SCALE 2019: Meeting Highlights from Music City
https://practicaldermatology.com/topics/practice-management/scale-2019-meeting-highlights-from-music-city/19619/With an emphasis on both medical and cosmetic dermatology as well as practice management, Music City Scale or the Symposium for Cosmetic Advances and Laser Education has something for everyone, organizers says. Co-chairs Michael Gold, MD and Brian Biesman, MD are joined by several presenters to discA Brief Compendium of Some Long-Forgotten Remedies for Dermatology
https://practicaldermatology.com/topics/general-topics/a-brief-compendium-of-some-long-forgotten-remedies-for-dermatology/20313/Is it time to drop the one-size-fits-all approach and consider remedies of the past?Challenges and Opportunities for the Dermatology Specialty
https://practicaldermatology.com/topics/practice-management/challenges-and-opportunities-for-the-dermatology-specialty/23881/Joining together may help address some of the issues facing board-certified dermatologists.A New Toxin Arrives
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-new-toxin-arrives/23035/The launch of Jeuveau creates a new opportunity for patients and physicians.Update on Atopic Dermatitis 2018
https://practicaldermatology.com/topics/general-topics/update-on-atopic-dermatitis-2018/20354/A look at the pathophysiology of AD, including structural and immunologic contributors, as well as new therapeutic developments with an eye toward breakthroughs on the horizon.Multiple Eruptive Myxoid Dermatofibromas in Patient With History of HIV
https://practicaldermatology.com/programs/practical-dermatology/multiple-eruptive-myxoid-dermatofibromas-in-patient-with-history-of-hiv/24216/Multiple eruptive dermatofibromas, a rare presentation of dermatofibroma, has been associated with altered immunity such as HIV/AIDS.Analyzing Safety Data From Level Up
https://practicaldermatology.com/series/the-practical-dermatology-podcast/analyzing-safety-data-from-level-up/33944/The latest news and updates, plus Matthew Zirwas, MD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss the importance of the Week 16 safety data from the Level Up study on upadacitinib. Silverberg JI, Bunick CG, et al. Efficacy and safety of upadacitinib versuKeratosis Pilaris: A Rough and Bumpy Review
https://practicaldermatology.com/columns/clinical-focus-1/keratosis-pilaris-a-rough-and-bumpy-review/23618/There are promising interventions for this challenging presentation.